Economic Impact and Clinical Outcomes of Omalizumab Add-On Therapy for Patients with Severe Persistent Asthma: A Real-World Study.
Entrenas Costa LM, Casas-Maldonado F, Soto Campos JG, Padilla-Galo A, Levy A, Álvarez Gutiérrez FJ, Gómez-Bastero Fernández AP, Morales-García C, Gallego Domínguez R, Villegas Sánchez G, Mateos Caballero L, Pereira-Vega A, García Polo C, Pérez Chica G, Martín Villasclaras JJ.
Entrenas Costa LM, et al.
Pharmacoecon Open. 2019 Sep;3(3):333-342. doi: 10.1007/s41669-019-0117-4.
Pharmacoecon Open. 2019.
PMID: 30684255
Free PMC article.